[Radiation and drug therapy of prostatic cancer].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001918:Brachytherapy / Q000379:methods; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004961:Estramustine / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use; D011344:Procarbazine / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011867:Radioisotope Teletherapy / Q000379:methods
D007457:Iodine Radioisotopes; D008937:Mitomycins; D010761:Phosphorus Radioisotopes; D004961:Estramustine; D011344:Procarbazine; D016685:Mitomycin; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Luchevaia i lekarstvennaia terapiia raka predstatel'noĭ zhelezy.